Details

Last Funding Type

Series Unknown

Industries

Bioinformatics,Biotechnology,Genetics,Health Care,Information Technology

Founded date

Jan 1, 2014

Number Of Employee

101 - 250

Operating Status

Active

ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology, cancer genomics, and bioinformatics. The company’s technology provides the possibility to transform cancer genomic information into precision diagnosis and personalized treatments.

Every patient’s cancer is unique at the molecular level. Specific genetic alterations drive the pathogenesis and determine the treatment response of individual tumor. Understanding the genetic alteration helps to design a more effective treatment strategy and provide a more accurate prediction for patient’s outcome. The use of genomics is changing the paradigm of oncology treatment decisions and making great impacts on personalized treatment. Such comprehensive tumor profiling is now affordable due to rapid progress in sequencing and informatics technologies.

ACT Genomics has acquired 1 organizations. Their most recent acquisition was MC Diagnostics on Jul 5, 2021. They acquired MC Diagnostics for 0.

Date Company Name	Industry	Acquisition Type	Price
Jul 5, 2021 MC Diagnostics	Biotechnology	acquisition	—	Detail